(3.228.10.17)
Users online: 2759    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2018, Volume : 11, Issue : 7
First page : ( 3081) Last page : ( 3086)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2018.00566.8

Formation of patent strategy at all stages of biosimilar development and Implementation

Litvinova Elena Vyacheslavna1,*, Posilkina Olga Viktorovna2, Maslova Nataliia Fedorovna3

1Candidate of Biology (PhD), Associate Professor of the National University of Pharmacy, National University of Pharmacy, Ukraine, 61002, Kharkov, 53 Pushkinska str

2Doctor of Pharmacy, Professor of the National Pharmaceutical University, National University of Pharmacy, Ukraine, 61002, Kharkov, 53 Pushkinska str

3Doctor of Biology, Professor of the State Enterprise “State Scientific Center of Drugs”, State Enterprise “State Scientific Center of Drugs”, Ukraine, 61085, Kharkov, 33 Astronomicheskaya str

*Corresponding Author E-mail: hlitvinova@gmail.com

Online published on 31 October, 2018.

Abstract

The aim of this study is to analyze the specificities formation of patent strategy at all stages of biosimilar development and implementation. Due to the complexity of biological medicinal product structure and the impossibility of accurate reproduction of technology, biosimilar can not be identical to a copy of the original biological medicinal product. The dependence of biological medicinal product from living cells, the functions of which inevitably vary, as well as the presence of impurities can significantly change the properties of biological medicinal product of different manufacturers. On the basis of the above, it follows that when creating a biosimilar there is a possibility of obtaining a new invention. It has established the possibility of biosimilar patent protection at all stages of the life cycle depending on the stage of preparation of registration dossier. It contributes to rational management of the intellectual capital of pharmaceutical companies and more effective drug provision of the population. It has been proved that various stages of the development and implementation of biosimilars should be accompanied by different types of their patenting (pharmaceutical composition, new dosage form, delivery method, optimization of the purification process, increase of stability, new indications for application or new treatment), etc. It has proposed author's algorithm for the formation of patent strategy of biosimilar development and implementation depending on the stage of preparation of the registration dossier.

Top

Keywords

Biosimilar, registration dossier, patent, strategy.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
445,384,463 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.